BR9714384A - Use of equeilenina as an antioxidant - Google Patents

Use of equeilenina as an antioxidant

Info

Publication number
BR9714384A
BR9714384A BR9714384-7A BR9714384A BR9714384A BR 9714384 A BR9714384 A BR 9714384A BR 9714384 A BR9714384 A BR 9714384A BR 9714384 A BR9714384 A BR 9714384A
Authority
BR
Brazil
Prior art keywords
antioxidant
equeilenina
equilenin
pharmaceutically acceptable
provides
Prior art date
Application number
BR9714384-7A
Other languages
Portuguese (pt)
Inventor
Steven Jay Adelman
Dorothy Helen Prozialeck
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9714384A publication Critical patent/BR9714384A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Abstract

Patente de Invenção:<B>"USO DE EQUILENINA COMO UM ANTIOXIDANTE"<D>. Esta invenção fornece um método usando equilenina ou um sal de éster equilenina-3-sulfato aceitável farmaceuticamente como um antioxidante.Invention Patent: <B> "USE OF EQUILENIN AS AN ANTIOXIDANT" <D>. This invention provides a method using equilenin or a pharmaceutically acceptable equilenin-3-sulfate ester salt as an antioxidant.

BR9714384-7A 1996-12-10 1997-12-05 Use of equeilenina as an antioxidant BR9714384A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76257996A 1996-12-10 1996-12-10
PCT/US1997/022154 WO1998025626A1 (en) 1996-12-10 1997-12-05 Use of equilenin as an antioxidant

Publications (1)

Publication Number Publication Date
BR9714384A true BR9714384A (en) 2000-05-16

Family

ID=25065472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714384-7A BR9714384A (en) 1996-12-10 1997-12-05 Use of equeilenina as an antioxidant

Country Status (14)

Country Link
EP (1) EP0944391A1 (en)
JP (1) JP2001506628A (en)
KR (1) KR20000069412A (en)
CN (1) CN1239892A (en)
AR (1) AR010344A1 (en)
AU (1) AU743586B2 (en)
BR (1) BR9714384A (en)
CA (1) CA2272087A1 (en)
HU (1) HUP0000569A3 (en)
IL (1) IL130071A0 (en)
NZ (1) NZ336343A (en)
TW (1) TW466115B (en)
WO (1) WO1998025626A1 (en)
ZA (1) ZA9711052B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271221B1 (en) * 1996-12-10 2001-08-07 American Home Products Corporation Use of equilenin as an antioxidant
DE19915576A1 (en) 1999-03-30 2000-10-05 Jenapharm Gmbh New equilenine derivatives, useful as antioxidative estrogenic hormonal steroids for e.g. prophylactic geriatrics in women and men
CA2466928A1 (en) * 2001-12-10 2003-07-03 Yansheng Du Treatment of neurodegenerative and cardiovascular disorders
CN108958639B (en) 2017-05-19 2021-07-06 华邦电子股份有限公司 Flash memory storage device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
EP0240717A3 (en) * 1986-03-04 1990-05-16 Board of Regents of the University of Nebraska Prevention of mammary carcinoma
US4937238A (en) * 1986-03-04 1990-06-26 The Board Of Regents Of The University Of Nebraska Prevention of mammary carcinoma
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin

Also Published As

Publication number Publication date
ZA9711052B (en) 1999-06-09
CA2272087A1 (en) 1998-06-18
NZ336343A (en) 2000-11-24
KR20000069412A (en) 2000-11-25
TW466115B (en) 2001-12-01
WO1998025626A1 (en) 1998-06-18
HUP0000569A3 (en) 2000-11-28
JP2001506628A (en) 2001-05-22
AU5370798A (en) 1998-07-03
HUP0000569A2 (en) 2000-10-28
CN1239892A (en) 1999-12-29
AR010344A1 (en) 2000-06-07
IL130071A0 (en) 2000-02-29
AU743586B2 (en) 2002-01-31
EP0944391A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
BR9902086A (en) Pharmaceutical formulations.
AU1126500A (en) Marker for indicating the location of identified tissue
DE69727384D1 (en) POLYCATONIC STERIN DERIVATIVES FOR TRANSFECTION
TR199801679T2 (en) Combination therapy for osteoporosis.
ES2182088T3 (en) ENDOTHELINE ANTAGONIST.
BR0113670A (en) Pharmaceutical composition and method for treating hypogonadism
BR9807638A (en) Anti-inflammatory compounds
EP1336600A3 (en) Dimer-selective RXR modulators and methods for their use
BR9712491A (en) Cosmetic compositions
ES2179881T3 (en) ENDOTHELINE ANTAGONISTS.
BR9813817A (en) Hemiasterline analogs
BR9707247A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
DE69935873D1 (en) 2-Methyl-thieno-benzodiazepine formulation
AU694663B2 (en) Agents for use against parasitic protozoa
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
BR9714384A (en) Use of equeilenina as an antioxidant
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
MXPA03002068A (en) Creatine ester pronutrient compounds and formulations.
BR9713176A (en) Amorphous benzothiophenes, methods of preparation and methods of use
AU2881399A (en) N1-modified glycopeptides
AU5430498A (en) Itinerary based agent mobility including mobility of executable code
BR9713998A (en) Use of 17beta-dihydroequilenin as an antioxidant
FR2756888B3 (en) BEARING BODY
IL139144A0 (en) Mycobacterial inhibitors
ES2174150T3 (en) PROCEDURE FOR OBTAINING 4-HYDROXIANILINS.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO 8.6 DA RPI 1879 DE 09/01/2007.